Di Eusanio Marco, Wesselink Ronald M J, Morshuis Wim J, Dossche Karl M, Schepens Marc A A M
Department of Cardiopulmonary Surgery, St Antonius Hospital, Nieuwegein, The Netherlands.
J Thorac Cardiovasc Surg. 2003 Apr;125(4):849-54. doi: 10.1067/mtc.2003.8.
We sought to compare the results of ascending aorta-hemiarch replacement by using 2 different methods of cerebral protection in terms of hospital mortality, neurologic outcome, and systemic morbidity and to determine predictive risk factors associated with hospital mortality and neurologic outcome after ascending aorta-hemiarch replacement.
Between January 1995 and September 2001, 289 patients (mean age, 62.2 +/- 13.2 years; urgent status, 122/289 [42.2%]) underwent ascending aorta-hemiarch replacement with the aid of antegrade selective cerebral perfusion (161 patients) or deep hypothermic circulatory arrest (128 patients).
Overall hospital mortality was 11.4% (deep hypothermic circulatory arrest group, 13.3%; antegrade selective cerebral perfusion group, 9.9%; P =.375). A logistic regression analysis revealed acute type A dissection (P =.001; odds ratio, 4.3) and age of greater than 70 years (P =.019; odds ratio, 2.5) to be independent predictors of hospital mortality. The permanent neurologic dysfunction rate was 9.3% (deep hypothermic circulatory arrest group, 12.5%; antegrade selective cerebral perfusion group, 7.6%; P =.075). Logistic regression analysis revealed acute type A dissection (P =.001; odds ratio, 6.7) and history of cerebral infarction-transient ischemic attack (P =.038; odds ratio, 3.4) to be independent predictors of permanent neurologic dysfunction. The transient neurologic dysfunction rate was 8.0% (deep hypothermic circulatory arrest group, 7.1%; antegrade selective cerebral perfusion group, 8.7%; P =.530). Acute type A dissection (P =.001; odds ratio, 5.1) was indicated as an independent predictor of transient neurologic dysfunction by means of logistic regression. Renal dysfunction (postoperative creatinine level of >250 micromol/L; deep hypothermic circulatory arrest, 10 [7.8%]; antegrade selective cerebral perfusion, 6 [3.7%]; P =.030), as well as prolonged intubation time (deep hypothermic circulatory arrest, 3.8 +/- 6.3 days; antegrade selective cerebral perfusion, 2.2 +/- 2.5 days; P =.005) were more common in the deep hypothermic circulatory arrest group.
The use of antegrade selective cerebral perfusion and deep hypothermic circulatory arrest during ascending aorta-hemiarch replacement resulted in acceptable hospital mortality and neurologic outcome. Reduced postoperative intubation time and better renal function preservation were observed in the antegrade selective cerebral perfusion group.
我们试图比较采用两种不同脑保护方法进行升主动脉 - 半弓置换术在医院死亡率、神经功能结局和全身并发症方面的结果,并确定与升主动脉 - 半弓置换术后医院死亡率和神经功能结局相关的预测风险因素。
在1995年1月至2001年9月期间,289例患者(平均年龄62.2±13.2岁;急诊状态,122/289 [42.2%])在顺行选择性脑灌注(161例患者)或深低温循环停搏(128例患者)辅助下接受了升主动脉 - 半弓置换术。
总体医院死亡率为11.4%(深低温循环停搏组,13.3%;顺行选择性脑灌注组,9.9%;P = 0.375)。逻辑回归分析显示急性A型夹层(P = 0.001;比值比,4.3)和年龄大于70岁(P = 0.019;比值比,2.5)是医院死亡率的独立预测因素。永久性神经功能障碍发生率为9.3%(深低温循环停搏组,12.5%;顺行选择性脑灌注组,7.6%;P = 0.075)。逻辑回归分析显示急性A型夹层(P = 0.001;比值比,6.7)和脑梗死 - 短暂性脑缺血发作史(P = 0.038;比值比,3.4)是永久性神经功能障碍的独立预测因素。短暂性神经功能障碍发生率为8.0%(深低温循环停搏组,7.1%;顺行选择性脑灌注组,8.7%;P = 0.530)。通过逻辑回归分析,急性A型夹层(P = 0.001;比值比,5.1)被表明是短暂性神经功能障碍的独立预测因素。肾功能障碍(术后肌酐水平>250μmol/L;深低温循环停搏组,10例[7.8%];顺行选择性脑灌注组,6例[3.7%];P = 0.030)以及延长的插管时间(深低温循环停搏组,3.8±6.3天;顺行选择性脑灌注组,2.2±2.5天;P = 0.005)在深低温循环停搏组中更为常见。
在升主动脉 - 半弓置换术中使用顺行选择性脑灌注和深低温循环停搏导致了可接受的医院死亡率和神经功能结局。在顺行选择性脑灌注组中观察到术后插管时间缩短和肾功能保存更好。